ARTICLE | Company News

Genzyme, Dana Farber Cancer Institute, Massachusetts General Hospital deal

May 9, 2005 7:00 AM UTC

GENZ received exclusive worldwide diagnostic rights from the hospital and the institute to mutations in the EGFr gene found in patients with non-small cell lung cancer (NSCLC). GENZ plans to develop a...